Show simple item record

dc.contributor.authorSadaba Larraona, Naroa
dc.contributor.authorLarrañaga Espartero, Aitor ORCID
dc.contributor.authorOrpella Aceret, Gemma
dc.contributor.authorBettencourt, Ana F.
dc.contributor.authorMartin, Victor
dc.contributor.authorBiggs, Manus
dc.contributor.authorRibeiro, Isabel A. C.
dc.contributor.authorMuñoz Ugartemendia, Jone ORCID
dc.contributor.authorSarasua Oiz, José Ramón ORCID
dc.contributor.authorZuza Hernández, Ester
dc.date.accessioned2020-09-03T11:40:49Z
dc.date.available2020-09-03T11:40:49Z
dc.date.issued2020-07-31
dc.identifier.citationInternational Journal of Molecular Sciences 21(15) : (2020) // Article ID 5480es_ES
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10810/45967
dc.description.abstractThis work reports the versatility of polydopamine (PD) when applied as a particle coating in a composite of polylactide (PLA). Polydopamine was observed to increase the particle–matrix interface strength and facilitate the adsorption of drugs to the material surface. Here, barium sulfate radiopaque particles were functionalized with polydopamine and integrated into a polylactide matrix, leading to the formulation of a biodegradable and X-ray opaque material with enhanced mechanical properties. Polydopamine functionalized barium sulfate particles also facilitated the adsorption and release of the antibiotic levofloxacin. Analysis of the antibacterial capacity of these composites and the metabolic activity and proliferation of human dermal fibroblasts in vitro demonstrated that these materials are non-cytotoxic and can be 3D printed to formulate complex biocompatible materials for bone fixation devices.es_ES
dc.description.sponsorshipThe authors express thanks for technical and human support provided by SGIker of UPV/EHU and European funding: European Regional Development Fund (ERDF) and European Social Fund (ESF).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjectbiodegradablees_ES
dc.subjectcompositees_ES
dc.subjectpolylactidees_ES
dc.subjectbarium sulfatees_ES
dc.subjectpolydopaminees_ES
dc.subjectmelt processinges_ES
dc.subjecttemplatees_ES
dc.subject3D-printinges_ES
dc.subjectscaffoldses_ES
dc.subjectantibiotices_ES
dc.subjectlevofloxacines_ES
dc.titleBenefits of Polydopamine as Particle/Matrix Interface in Polylactide/PD-BaSO4 Scaffoldses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2020-08-07T13:38:00Z
dc.rights.holder2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/21/15/5480es_ES
dc.identifier.doi10.3390/ijms21155480
dc.departamentoesIngeniería Minera y Metalúrgica y Ciencia de los Materiales
dc.departamentoeuMeatze eta metalurgia ingeniaritza materialen zientzia


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).